To save one life is as if to save the world.

- The Talmud

Archive - Feb 14, 2012


Will Anti-Arryhthymic Drug Beat SCA?

Sudden Cardiac Arrest (SCA) is the leading cause of death in the United States.  SCA kills 325,000 people every year, representing one death every two minutes. Almost all SCA victims die before they even reach a hospital. To identify a drug that paramedics can use in the field, UC San Diego Health System has opened a clinical trial to evaluate two medications to help restore the heart beat.

“Only five percent of sudden cardiac arrest victims survive their (heart attack),” said Daniel Davis, MD, UC San Diego Director of Resuscitation Science in the Department of Emergency Medicine. “For more than 30 years we’ve been looking for an anti-arrhythmic drug to treat ventricular tachycardia, or what we call shockable rhythm, but we have not found a drug that consistently improves patient outcomes. This clinical trial will help us determine if either the drugs amiodarone or lidocaine may help prevent death.”

Survey: Most Americans Unfamiliar with Heart Rhythm Disorders and SCA

Washington, D.C. - According to a new survey issued by the Heart Rhythm Society, the majority of Americans are unaware of two serious and potentially life-threatening heart rhythm disorders: atrial fibrillation (AF) and sudden cardiac arrest (SCA). In fact, only one in three Americans has ever heard of AF or recognize the number of lives claimed each year from SCA. Throughout February, Heart Health Month, the Heart Rhythm Society spotlights the need for public education on heart rhythm disorders affecting millions of people, and the specialists best suited to treat them – electrophysiologists.